CIP2A antibody

Synonyms:Cancerous inhibitor of PP2A antibody, CIP2A antibody, KIAA1524 antibody, p90 antibody, p90 autoantigen antibody, Protein CIP2A antibody
Catalogue No.:FNab10835Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
CIP2A antibody
Catalogue No.
FNab10835
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
KIAA1524
Alternative Names
Cancerous inhibitor of PP2A antibody, CIP2A antibody, KIAA1524 antibody, p90 antibody, p90 autoantigen antibody, Protein CIP2A antibody
UniProt ID
Q8TCG1
Observed MW
102 kDa
Application
Tested Applications
ELISA, WB
Recommended dilution
WB: 1:500 - 1:2000
Validated Images
HepG2 cells were subjected to SDS PAGE followed by western blot with FNab10835(CIP2A antibody) at dilution of 1:1000
Background
Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein.